Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Ushiku, Japan Clinical Trials

A listing of Ushiku, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (35) clinical trials

A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) compared to placebo (PBO) as adjunctive treatment in subjects (>=16 to 80 years of age) with partial seizures with or without secondary generalization despite current treatment with 1 or 2 concomitant antiepileptic drugs (AEDs) and to assess …

Phase

0.0 miles

Learn More »

Image Fusion System for 3D Preoperative Planning in the Osteosynthesis

The fracture patients need osteosynthesis will be recruited. Image fusion group utilizes 3D preoperative planning and image fusion system. Control group utilizes only 3D preoperative planning. The age, sex, and fracture types will be macthed between groups. In both groups, 3D preoperative planning will be performed in order to determine …

Phase N/A

5.09 miles

Learn More »

Development of Three Dimensional Preoperative Planning System for the Osteosynthesis of Distal Humerus Fractures

To reproduce anatomical reduction and appropriate implant placement/choices during osteosynthesis for elbow fractures, we develop a 3D preoperative planning system. To assess the utility of 3D digital preoperative planning for the osteosynthesis of distal humerus fractures, we evaluate the reproducibility of implant reduction shapes and placements in patients with distal …

Phase N/A

5.09 miles

Learn More »

A Study to Test BI 655130 in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

To evaluate efficacy, safety, and tolerability of BI 655130 compared to placebo in patients with Generalized Pustular Psoriasis (GPP) presenting with an acute flare of moderate to severe intensity

Phase

5.46 miles

Learn More »

Three Dimensional Digital Preoperative Planning for the Osteosynthesis of Distal Radius Fractures

Patients and Methods The study protocol was approved by our Institutional Review Board. Thirty wrists of 30 distal radius fracture patients who underwent osteosynthesis using locking plates (19 females, 11 males; age range 23-89, mean age 59.5 years) were evaluated. Patients were excluded if they reported a previous history of …

Phase N/A

5.46 miles

Learn More »

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

Phase

5.46 miles

Learn More »

Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.

This is an international, multicentre, parallel-group, event-driven, randomised, double-blind study in patients with HFpEF, evaluating the effect of dapagliflozin 10 mg versus placebo, given once daily in addition to background regional standard of care therapy, including treatments to control co-morbidities, in reducing the composite of CV death and heart failure …

Phase

6.75 miles

Learn More »

Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of antiplatelet therapy in patients following a recent non cardioembolic ischemic stroke which occurs when a …

Phase

6.75 miles

Learn More »

A Study to Confirm Safety and Efficacy of BAN2401 in Participants With Early Alzheimer's Disease

This study will be conducted to evaluate the efficacy of BAN2401 in participants with early Alzheimer's disease (EAD) by determining the superiority of BAN2401 compared with placebo on the change from baseline in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) at 18 months of treatment in the Core Study. This …

Phase

7.9 miles

Learn More »